CIK: 0001325083 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Dec 9, 2014
Total Value ($000): $257,075
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Medivation, Inc. | 2,244,519 | $221,916 | 86.3% | $49.20 | — | — | 58501N101 |
| — | Ampio Pharmaceuticals Inc. | 3,370,822 | $12,000 | 4.7% | $6.03 | — | — | 03209T109 |
| — | Alcobra Ltd | 687,000 | $10,607 | 4.1% | $8.47 | — | — | M2239P109 |
| — | Keryx Biopharmaceuticals Inc. | 200,000 | $2,750 | 1.1% | $10.21 | — | — | 492515101 |
| — | Bio Blast Pharma Ltd | 338,110 | $2,458 | 1.0% | $7.27 | — | — | M20156101 |
| — | Synthetic Biologics Inc. | 1,360,000 | $2,394 | 0.9% | $1.51 | — | — | 87164U102 |
| — | Newlink Genetics Corp | 77,437 | $1,659 | 0.6% | $19.35 | — | — | 651511107 |
| — | Inovio Pharmaceuticals Inc. | 102,088 | $1,006 | 0.4% | $10.86 | — | — | 45773H201 |
| — | Advaxis Inc. | 225,000 | $756 | 0.3% | $3.36 | — | — | 007624208 |
| — | Galmed Pharmaceuticals Ltd | 65,000 | $559 | 0.2% | $11.48 | — | — | M47238106 |
| NWBO | Northwest Biotherapeutics Inc | 67,035 | $337 | 0.1% | $5.93 | +3.7% | — | 66737P600 |
| — | Nephrogenex Inc | 50,000 | $234 | 0.1% | $8.24 | — | — | 640667101 |
| PVCT | Provectus Biopharmaceuticals | 200,000 | $204 | 0.1% | $1.90 | -48.9% | — | 74373P108 |
| — | Advaxis Inc. | 112,500 | $162 | 0.1% | $1.44 | — | — | 007624117 |
| — | Cellectar Biosciences Inc | 14,634 | $33 | 0.0% | $2.26 | — | — | 15117F203 |